Immune attack: the role of inflammation in Alzheimer disease

Heppner, Frank L., Ransohoff, Richard M., Becher, Burkhard·2015·Nature Reviews Neuroscience
DOI 10.1038/nrn3880

Cited by (1,003)

Items 401–500 of 1,003

  1. Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem study
    Ricardo Jorge Ferreira Taipa, Vítor Ferreira, Paulo Brochado, Andrew Robinson, I. Reis, Fernanda Marques, David M. A. Mann, Manuel Melo Pires, Nuno Sousa · 2017 · Neuropathology and Applied Neurobiology
  2. Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer’s Disease
    Huang, Qianqian, Jiang, Chaoqing, Xia, Xue, Wang, Yufan, Yan, Chenxing, Wang, Xiaorong, Lei, Ting, Yang, Xiaotong, Yang, Wenqin, Cheng, Guo et al. · 2023 · Research
  3. Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation
    Ralvenius, William T., Andresen, Jason L., Huston, Margaret M., Penney, Jay, Bonner, Julia Maeve, Fenton, Owen S., Langer, Robert, Tsai, Li‐Huei · 2024 · Advanced Materials
  4. Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice
    Kathryn E. Hopperton, Marc‐Olivier Trépanier, Vanessa Giuliano, Richard Paul Bazinet · 2016 · Journal of Neuroinflammation
  5. TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Paramita Chakrabarty, Andrew Li, Thomas B. Ladd, Michael R. Strickland, Emily J. Koller, Jeremy D. Burgess, Cory C. Funk, Pedro E. Cruz, Mariet Allen, Mariya Yaroshenko et al. · 2018 · The Journal of Experimental Medicine
  6. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
    Alexei Verkhratsky, Qing Li, Sonia Melino, Gerry Melino, Yufang Shi · 2020 · Biology Direct
  7. Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential
    Kanchan Bhardwaj, Ana T. Sanches-Silva, Maria Atanassova, Rohit Sharma, Eugenie Nepovimová, Kamil Musílek, Ruchi Sharma, Mousa Abdullah Alghuthaymi, Daljeet Singh Dhanjal, Marcello Nicoletti et al. · 2021 · Molecules
  8. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities
    Francesca Pistollato, Elan Liss Ohayon, Ann Lam, Gillian R. Langley, Thomas J. Novak, David Pamies, George L. Perry, Eugenia V. Trushina, Robin S. B. Williams, Alex E. Roher et al. · 2016 · Oncotarget
  9. Alternative splicing in Alzheimer’s disease
    Giuseppe Biamonti, Angela M. Amato, Elisa Belloni, Anna Di Matteo, Lucia Infantino, Davide Pradella, Claudia Ghigna · 2019 · Aging Clinical and Experimental Research
  10. Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
    Maria Assunta Potenza, Luca Sgarra, Vanessa Desantis, Carmela Nacci, Monica Montagnani · 2021 · Antioxidants
  11. Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis
    Dagmara Kociszewska, Srdjan M. Vlajkovic · 2022 · International Journal of Molecular Sciences
  12. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline
    Lauren N. Macklin, Chelsea M. Griffith, Yan Cai, Gregory M. Rose, Xiao‐Xin Yan, Peter R. Patrylo · 2016 · Experimental Gerontology
  13. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease
    Liang Ma, Chen Yang, Xia Zhang, Yang Li, Shun Li Wang, Ling Zheng, Kun Huang · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  14. Metabolic profiling distinguishes three subtypes of Alzheimer's disease
    Bredesen, Dale E. · 2015 · Aging
  15. Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
    Franziska Radtke, Gareth Chapman, Jérémy Hall, Yasir Ahmed Syed · 2017 · BioMed Research International
  16. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease
    Amanda Ferreira Neves, Christian J. Camargo, Courtney Premer, Joshua M. Hare, Bernard S. Baumel, Milena Pinto · 2021 · Experimental Neurology
  17. Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
    Xiaopu Zhou, Yu Chen, Fanny C.F. Ip, Yuanbing Jiang, Han Cao, Ge Lv, Huan Zhong, Jiahang Chen, Ye Tao, Yuewen Chen et al. · 2023 · Communications Medicine
  18. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
    Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek‐Kamińska, Ireneusz Majsterek · 2023 · International Journal of Molecular Sciences
  19. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice
    Evi Paouri, Ourania Tzara, Georgia-Ioanna Kartalou, Sofia Zenelak, Spiros Georgopoulos · 2017 · Journal of Neuroscience
  20. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
    Cerami, Chiara, Iaccarino, Leonardo, Perani, Daniela · 2017 · International Journal of Molecular Sciences
  21. A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation
    Rangaraju, Srikant, Raza, Syed Ali, Pennati, Andrea, Deng, Qiudong, Dammer, Eric B., Duong, Duc, Pennington, Michael W., Tansey, Malu G., Lah, James J., Betarbet, Ranjita et al. · 2017 · Journal of Neuroinflammation
  22. Efficacy and mechanism of cGAMP to suppress Alzheimer’s disease by elevating TREM2
    Xu, Qiming, Xu, Wei, Cheng, Hao, Yuan, Hong, Tan, Xiangshi · 2019 · Brain, Behavior, and Immunity
  23. Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review
    Zahra Haghighijoo, Leila Zamani, Fatemeh Moosavi, Saeed Emami · 2021 · European Journal of Medicinal Chemistry
  24. New Drugs from Marine Organisms in Alzheimer’s Disease
    Patrizia Russo, Aliaksei Kisialiou, Palma Lamonaca, Rossana Moroni, Giulia Prinzi, Massimo Fini · 2015 · Marine Drugs
  25. Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer’s disease mouse model
    Chiara Criscuolo, Veronica Fontebasso, Silvia Middei, Martina Stazi, Martine Ammassari‐Teule, Shirley ShiDu Yan, Nicola Origlia · 2017 · Scientific Reports
  26. Innate immune activation in Alzheimer’s disease
    Mingming Wang, Dan Miao, Xi‐Peng Cao, Lin Tan, Lan Tan · 2018 · Annals of Translational Medicine
  27. Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH)
    Rebecca Heinz, Susan Brandenburg, Melina Nieminen-Kelhä, Irina Kremenetskaia, Philipp Boehm‐Sturm, Peter Vajkoczy, Ulf Christoph Schneider · 2021 · Journal of Neuroinflammation
  28. Opening up the DNA methylome of dementia
    Raúl Delgado‐Morales, Manel Esteller · 2017 · Molecular Psychiatry
  29. Bioengineered 3D Glial Cell Culture Systems and Applications for Neurodegeneration and Neuroinflammation
    Watson, P. Marc D., Kavanagh, Edel, Allenby, Gary, Vassey, Matthew · 2017 · SLAS Discovery
  30. Trigonelline insulates against oxidative stress, proinflammatory cytokines and restores BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice
    Amrita A. Chowdhury, Nitin Bhanudas Gawali, Renuka Munshi, Archana Ramesh Juvekar · 2017 · Metabolic Brain Disease
  31. The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review
    Yun Freudenberg‐Hua, Wentian Li, Peter Davies · 2018 · Frontiers in Medicine
  32. The Dual Role of Hepcidin in Brain Iron Load and Inflammation
    Driton Vela · 2018 · Frontiers in Neuroscience
  33. Traumatic brain injury increases plasma astrocyte‐derived exosome levels of neurotoxic complement proteins
    Edward J. Goetzl, Kristine S. Yaffe, Carrie Brumback Peltz, Aurélie Ledreux, Kim A. Gorgens, Bradley S. Davidson, Ann‐Charlotte Granholm, Maja Mustapić, Dimitrios Kapogiannis, David Tweedie et al. · 2020 · The FASEB Journal
  34. Neuroimmune contributions to Alzheimer’s disease: a focus on human data
    Haage, Verena, De Jager, Philip L. · 2022 · Molecular Psychiatry
  35. The neuroprotective effect of doxycycline on neurodegenerative diseases
    Santa-Cecília, Flávia Viana, Leite, Caio Abner, Del-Bel, Elaine, Raisman-Vozari, Rita · 2019 · Neurotoxicity Research
  36. Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease
    Yin, Ping, Wang, Xu, Wang, Shuang, Wei, Yafen, Feng, Jiachun, Zhu, Mingqin · 2019 · Frontiers in Cellular Neuroscience
  37. Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease
    Virginia Boccardi, Marta Baroni, Francesca Mangialasche, Patrizia Mecocci · 2016 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  38. Posttranslational modification impact on the mechanism by which amyloid‐β induces synaptic dysfunction
    Katarzyna M. Grochowska, PingAn Yuanxiang, Julia Bär, Rajeev Raman, Gemma Navarro Brugal, Giriraj Sahu, Michaela Schweizer, Arthur F. Bikbaev, Stephan Schilling, Hans‐Ulrich Demuth et al. · 2017 · EMBO Reports
  39. Neutrophils and Asthma
    Akira Yamasaki, Ryota Okazaki, Tomoya Harada · 2022 · Diagnostics
  40. Social-Biological Interactions in Oral Disease: A ‘Cells to Society’ View
    Noha A. Gomaa, Michael Glogauer, Howard Charles Tenenbaum, Arjumand Siddiqi, Carlos Quiñonez · 2016 · PLoS ONE
  41. Human IL‐6, IL ‐17, IL ‐1β, and TNF ‐α differently regulate the expression of pro‐inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells
    Hanchao Gao, Lu Liu, Yanli Zhao, Hidetaka Hara, Pengfei Chen, Jiajia Xu, Jia Tang, Ling Wei, Zesong Li, David K. C. Cooper et al. · 2017 · Xenotransplantation
  42. Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease
    Yumiko Oishi, Ichiro Manabe · 2018 · Frontiers in Cardiovascular Medicine
  43. P2X7 as a scavenger receptor for innate phagocytosis in the brain
    Ben J. Gu, James S. Wiley · 2018 · British Journal of Pharmacology
  44. Exposure to Ambient Air Pollution and Cognitive Impairment in Community-Dwelling Older Adults: The Korean Frailty and Aging Cohort Study
    Jinyoung Shin, S. Duke Han, Jaekyung Choi · 2019 · International Journal of Environmental Research and Public Health
  45. Astrocyte dysfunction and neurovascular impairment in neurological disorders: Correlation or causation?
    Heather McConnell, Zhenzhou Li, Randall L. Woltjer, Anusha Mishra · 2019 · Neurochemistry International
  46. Functional conservation in genes and pathways linking ageing and immunity
    Daniel K. Fabian, Matías Fuentealba, Handan Melike Dönertaş, Linda Partridge, Janet M. Thornton · 2021 · Immunity & Ageing
  47. The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer’s disease: a narrative review
    Qian Zhang, Yaping Yan · 2023 · Neural Regeneration Research
  48. Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
    Daniela Melchiorri, Sara Merlo, Benjamin Micallef, John-Joseph Borg, František Dráfi · 2023 · Frontiers in Pharmacology
  49. Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease
    Ya Wei, Xue Xia, Xiaorong Wang, Wenqin Yang, Siqin He, Lulu Wang, Yongke Chen, Yang Zhou, Feng Chen, Hanmei Li et al. · 2025 · Acta Pharmaceutica Sinica B
  50. The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model
    Ghazaleh Mohammadi, Leila Dargahi, Amir Peymani, Yazdan Mirzanejad, Safar Ali Alizadeh, Taghi Naserpour, Marjan Nassiri‐Asl · 2018 · Journal of the American College of Nutrition
  51. Noninvasive characterization of Alzheimer’s disease by circulating, cell-free messenger RNA next-generation sequencing
    Shusuke Toden, Jia-Li Zhuang, Alexander D. Acosta, Amy P. Karns, N. Salathia, J. Brewer, D. Wilcock, Jonathan Aballi, M. Nerenberg, S. Quake et al. · 2020 · Science Advances
  52. Complement C3aR depletion reverses HIF-1α–induced metabolic impairment and enhances microglial response to Aβ pathology
    Manasee Gedam, Michele M. Comerota, Nicholas E. Propson, Tao Chen, Feng Jin, Meng Carla Wang, Hui Zheng · 2023 · Journal of Clinical Investigation
  53. The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders
    Valeria Bruno, Filippo Caraci, Agata Copani, Francesco Matrisciano, Ferdinando Nicoletti, Giuseppe Battaglia · 2016 · Neuropharmacology
  54. A myeloperoxidase-responsive and biodegradable luminescent material for real-time imaging of inflammatory diseases
    Jiawei Guo, Hui Tao, Yin Dou, Lanlan Li, Xiaoqiu Xu, Qixiong Zhang, Juan Cheng, Songling Han, Jun Huang, Xiaodong Li et al. · 2017 · Materials Today
  55. Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood
    Paula Desplats, Ashley M. Gutierrez, Marta Cristina Antonelli, Martin Gerbert Frasch · 2019 · Neuroscience & Biobehavioral Reviews
  56. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice
    Lifen Liu, Yutong Liu, Nana Li, Runzhi Huang, Ximing Zheng, Liang Huang, Shuang-Xin Hou, Qionglan Yuan · 2020 · Brain Research Bulletin
  57. Citrus Polyphenols in Brain Health and Disease: Current Perspectives
    Matthew G. Pontifex, Mohammad Malik, Emily Connell, Michael M. Müller, David Vauzour · 2021 · Frontiers in Neuroscience
  58. Neuroinflammatory remodeling of the anterior cingulate cortex as a key driver of mood disorders in gastrointestinal disease and disorders
    Chelsea E. Matisz, Aaron J. Gruber · 2021 · Neuroscience & Biobehavioral Reviews
  59. The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
    Alzheimer’s Disease Neuroimaging Initiative, Luke W. Bonham, Rahul S. Desikan, Jennifer S. Yokoyama · 2016 · Acta Neuropathologica Communications
  60. In vivo PET imaging of neuroinflammation in Alzheimer’s disease
    Julien Lagarde, Marie Sarazin, Michel Bottlaender · 2017 · Journal of Neural Transmission
  61. Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats
    Emanuela Mhillaj, Maria Grazia Morgese, Paolo Tucci, Anna Furiano, Livio Luongo, María Bové, Sabatino Maione, V. Cuomo, Stefania Schiavone, Luigia Trabace · 2018 · Neuroscience
  62. Altered microglia and neurovasculature in the Alzheimer's disease cerebellum
    Malvindar K. Singh‐Bains, Vanessa Linke, Micah D. R. Austria, Adelie Y. S. Tan, Emma L. Scotter, Nasim F. Mehrabi, Richard L. M. Faull, Mike Dragunow · 2019 · Neurobiology of Disease
  63. Impact of Mesenchymal Stem Cell Senescence on Inflammaging
    Byung-Chul Lee, Kyung–Rok Yu · 2020 · BMB Reports
  64. Low-grade peripheral inflammation affects brain pathology in the AppNL-G-Fmouse model of Alzheimer’s disease
    Junhua Xie, Nina Gorlé, Charysse Vandendriessche, Griet Van Imschoot, Elien Van Wonterghem, Caroline Van Cauwenberghe, Eef Parthoens, Evelien Van Hamme, Saskia Lippens, Lien Van Hoecke et al. · 2021 · Acta Neuropathologica Communications
  65. The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders
    João P. Luís, Carlos J. V. Simões, Rui M. M. Brito · 2022 · International Journal of Molecular Sciences
  66. Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
    Grazia Daniela Femminella, Tony Thayanandan, Valeria Calsolaro, Klara Komici, Giuseppe Rengo, Graziamaria Corbi, Nicola Ferrara · 2018 · International Journal of Molecular Sciences
  67. Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer’s Disease-Related Pathologies in Wild-Type Mice
    Mona Abdelhamid, Chunyu Zhou, Cha‐Gyun Jung, Makoto Michikawa · 2022 · Nutrients
  68. Loganin prevents BV‐2 microglia cells from Aβ1‐42‐induced inflammation via regulating TLR4/TRAF6/NF‐κB axis
    Yong Cui, Yanjie Wang, Danyu Zhao, Xiaofan Feng, Lin Zhang, Chun Liu · 2018 · Cell Biology International
  69. Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci
    Aree Witoelar, Arvid Rongve, Ina S. Almdahl, Ingun Dina Ulstein, Andreas Engvig, Linda Rosemary White, Geir Selbæk, Eystein Stordal, Fred Andersen, Anne Brækhus et al. · 2018 · Scientific Reports
  70. Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease via Peroxisome Proliferator-Activated Receptor α
    Sujyoti Chandra, Kalipada Pahan · 2019 · Journal of Alzheimer s Disease Reports
  71. Alzheimer's disease: Innate immunity gone awry?
    VanItallie, Theodore B. · 2017 · Metabolism
  72. Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
    Brown, Madeleine R., Radford, Sheena E., Hewitt, Eric W. · 2020 · Frontiers in Molecular Neuroscience
  73. Influenza vaccination in early Alzheimer’s disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells
    Yunjie Yang, Zitian He, Zhiwei Xing, Zejie Zuo, Lifang Yuan, Yingying Wu, Mei Hua Jiang, Fangfang Qi, Zhibin Yao · 2020 · Journal of Neuroinflammation
  74. The impact of cell type and context-dependent regulatory variants on human immune traits
    Zepeng Mu, Wei Wei, Benjamin Jung Fair, Jinlin Miao, Ping Zhu, Yang Li · 2021 · Genome biology
  75. Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection
    Alice Laroni, Nicole Kerlero de Rosbo, Antonio Uccelli · 2015 · Immunology Letters
  76. Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease
    Benoit Lehallier, Laurent Essioux, Javier Gayán, Roxana A. Alexandridis, Tania Nikolcheva, Tony Wyss‐Coray, Markus Britschgi, Alzheimer’s Disease Neuroimaging Initiative · 2015 · JAMA Neurology
  77. Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1/M2 balance in vitro
    Claudio D Humeres, Raúl Vivar, Pía Boza, Claudia Muñoz, Samir Bolívar, Renatto Anfossi, José Miguel Osorio, Francisco Olivares-Silva, Lorena Garcı́a, Guillermo Dı́az-Araya · 2016 · Journal of Molecular and Cellular Cardiology
  78. The role of the immunoproteasome in interferon-γ-mediated microglial activation
    Kasey E. Moritz, Nikki M. McCormack, Mahlet B. Abera, Coralie Viollet, Young J. Yauger, Gauthaman Sukumar, Clifton L. Dalgard, Barrington G. Burnett · 2017 · Scientific Reports
  79. Mass cytometry analysis of immune cells in the brain
    Ben Korin, Tania Dubovik, Asya Rolls · 2018 · Nature Protocols
  80. The leukotriene signaling pathway: a druggable target in Alzheimer’s disease
    Johanna Michael, Julia Marschallinger, Ludwig Aigner · 2018 · Drug Discovery Today
  81. A Perspective of AMD Through the Eyes of Immunology
    Copland, David A., Theodoropoulou, Sofia, Liu, Jian, Dick, Andrew D. · 2018 · Investigative Opthalmology & Visual Science
  82. Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities
    Guanqun Zhan, Junfei Zhou, Rong Liu, Tingting Liu, Guoli Guo, Jianping Wang, Ming Xiang, Yongbo Xue, Zengwei Luo, Yonghui Zhang et al. · 2016 · Journal of Natural Products
  83. Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer’s disease
    Pritam Sadhukhan, Sukanya Saha, Sayanta Dutta, Sushweta Mahalanobish, Parames Chandra Sil · 2017 · Pharmacological Research
  84. Preventive Effects of Dairy Products on Dementia and the Underlying Mechanisms
    Yasuhisa Ano, Hiroyuki Nakayama · 2018 · International Journal of Molecular Sciences
  85. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer’s disease: Design, synthesis and biological evaluation
    Chaoquan Tian, Xiaoming Qiang, Qing Song, Zhongcheng Cao, Chanyuan Ye, Yuxi He, Yong Deng, Li Zhang · 2019 · Bioorganic Chemistry
  86. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics
    Carlyle, Becky C., Kandigian, Savannah E., Kreuzer, Johannes, Das, Sudeshna, Trombetta, Bianca A., Kuo, Yikai, Bennett, David A., Schneider, Julie A., Petyuk, Vladislav A., Kitchen, Robert R. et al. · 2021 · Neurobiology of Aging
  87. The Role of Neuroinflammation in Glaucoma: An Update on Molecular Mechanisms and New Therapeutic Options
    Teresa Rolle, Antonio Ponzetto, Lorenza Malinverni · 2021 · Frontiers in Neurology
  88. Psychedelic‐inspired approaches for treating neurodegenerative disorders
    Hannah N. Saeger, David E. Olson · 2021 · Journal of Neurochemistry
  89. Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective
    Molly M. Fox, Delaney A. Knorr, Kacey P. Haptonstall · 2019 · Annals of the New York Academy of Sciences
  90. Iron Pathophysiology in Alzheimer’s Diseases
    Wang, Tao, Xu, Shuang-Feng, Fan, Yong-Gang, Li, Lin-Bo, Guo, Chuang · 2019 · Advances in experimental medicine and biology
  91. NEUROINFLAMAÇÃO NA DOENÇA DE ALZHEIMER
    Annelisa Pimentel Rezende Machado, Izabella Oliveira Carvalho, Hermínio Maurício da Rocha Sobrinho · 2020 · Revista Brasileira Militar de Ciências
  92. Role of melatonin in Alzheimer’s disease: From preclinical studies to novel melatonin-based therapies
    Jaydeep Roy, K. Y. Wong, Luca Aquili, Md. Sahab Uddin, Boon Chin Heng, George Lim Tipoe, Kah-Hui Wong, Man‐Lung Fung, Lee Wei Lim · 2022 · Frontiers in Neuroendocrinology
  93. Dual roles of interleukin-33 in cognitive function by regulating central nervous system inflammation
    Xiuqin Rao, Fuzhou Hua, Lieliang Zhang, Yue Lin, Pu Fang, Shoulin Chen, Jun Ying, Xifeng Wang · 2022 · Journal of Translational Medicine
  94. Potential therapeutic role of melatonin on STZ-induced diabetic central neuropathy: A biochemical, histopathological, immunohistochemical and ultrastructural study
    Mohamed M.M. Metwally, Lamiaa L.M. Ebraheim, Azza A.A. Galal · 2018 · Acta Histochemica
  95. Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease
    Trongha Phan, Roneil Gopal Malkani · 2018 · Neurobiology of Stress
  96. Microglial Function during Glucose Deprivation: Inflammatory and Neuropsychiatric Implications
    Churchward, Matthew A., Tchir, Devan R., Todd, Kathryn G. · 2018 · Molecular Neurobiology
  97. Selenium-core nanozymes dynamically regulates Aβ & neuroinflammation circulation: Augmenting repair of nervous damage
    Youcong Gong, Anlian Huang, Xian Guo, Jia Zhi, Xu Chen, Xufeng Zhu, Yu Xia, Jie Liu, Ying Xu, Xiu‐Ying Qin · 2021 · Chemical Engineering Journal
  98. Early-Life Toxic Insults and Onset of Sporadic Neurodegenerative Diseases—an Overview of Experimental Studies
    Anna Maria Tartaglione, Aldina Venerosi, Gemma Calamandrei · 2015 · Current topics in behavioral neurosciences
  99. Complement Biomarkers as Predictors of Disease Progression in Alzheimer’s Disease
    Svetlana Hakobyan, Katharine Elizabeth Harding, Mohammed Aiyaz, Abdul Hye, Richard Dobson, Alison L. Baird, Benjamine Liu, Claire Louise Harris, Simon Lovestone, B. Paul Morgan · 2016 · Journal of Alzheimer s Disease
  100. Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer’s Disease
    Michał Wiciński, Eryk Wódkiewicz, Maciej Słupski, Maciej Walczak, Maciej Władysław Socha, Bartosz Malinowski, Katarzyna Pawlak-Osińska · 2018 · BioMed Research International